[The breast cancer risk in postmenopausal estrogen substitution. The dilemma of risk assessment].
Lippert
T H
TH
Sektion Klinische Pharmakologie, Frauenklinik, Eberhard-Karls-Universität Tübingen.
Mück
A O
AO
D001943:Breast Neoplasms / Q000139:chemically induced* / Q000378:metabolism; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000378:metabolism; D005260:Female; D006801:Humans; D018570:Risk Assessment; D012307:Risk Factors
D004967:Estrogens